This is the research your referring too and the one I think we will hear about in the near future. I'm guessing it will take a partnership with big pharma, maybe Teva? To get the expensive costs of orphan drug covered. This is the study that takes the share price into double digits overnight once its announced to move to orphan drug.

http://www.prnewswire.com/news-releases/owc-p...24291.html